Skip to content
AnalystLens
Back to ROIVIncome Statement

Roivant Sciences Net Income 2021-2027 | ROIV

Annual FY2021–FY2026 · quarterly through Q1 FY2027

Latest annual · FY2026

−$299.8M

−74.3%YoY vs FY2025Source: 10-KFY2026

From −$809.2M in FY2021 to −$299.8M in FY2026.

By quarter▲▼ vs a year before
Fiscal yearQ1Q2Q3Q4
FY27−$190M+15.0%Not reportedNot reportedNot reported
FY26−$223M−334.4%−$114M+50.7%−$266M−257.0%$303M+246.7%
FY25$95M+132.7%−$230M+24.4%$169M−96.7%−$206M−36.6%
FY24−$292M+12.1%−$304M−4.4%$5.1B+1547.7%−$151M−349.5%
FY23−$332M−303.7%−$292M−39.9%−$352M−23.7%−$34M+87.6%

Shaded by size: darkest is the largest quarter shown; ringed is the latest reported; a dash marks a quarter with no separate figure. Each quarter sits by its period-end date.

Key Statistics

Trend DirectionDeclining
CAGR

N/A

FY2021
−$809.2M
FY2026
−$299.8M

5 years selected · on the chart

Net Income History

Year-over-year comparison from 10-K annual reports

  1. −$299.8M
YoY changeLargest recent move−19.4%in FY23Latest −74.3%

1 older move runs past ±150% (largest +531.0%); point at, tap or drag across the bars to read one.

Net Income, period by period

PeriodValueChangeSource
FY2026−$299.8M−74.3%10-K
FY2025−$172.0M−104.0%10-K
FY2024$4.35B+531.0%10-K
FY2023−$1.01B−19.4%10-K
FY2022−$845.3M−4.5%10-K
FY2021−$809.2M—10-K

What is net income?

Net income can be defined as the company's total earnings or profit. It is calculated as revenues minus all expenses including cost of goods sold, operating expenses, interest, and taxes.

What is Roivant Sciences's current net income?

Roivant Sciences (ROIV) annual net income for 2026 was $-299.8M, a 74.30% decline from 2025. Roivant Sciences net income for the quarter ending June 30, 2026 was $-189.8M.

What was Roivant Sciences's net income in 2025?

Roivant Sciences annual net income for 2025 was $-172.0M, a 103.95% decline from 2024.

What was Roivant Sciences's net income in 2024?

Roivant Sciences annual net income for 2024 was $4.35B, a 531.00% increase from 2023.

Company
Roivant Sciences
Ticker
ROIV
Sector
Healthcare
Industry
Pharmaceutical Preparations